EMEA-000237-PIP01-08-M08

Key facts

Invented name
Edarbi
Active substance
Azilsartan medoxomil
Therapeutic area
Cardiovascular diseases
Decision number
P/0034/2019
PIP number
EMEA-000237-PIP01-08-M08
Pharmaceutical form(s)
  • Tablets
  • Granules for oral suspension
Condition(s) / indication(s)
Treatment of hypertension
Route(s) of administration
Oral use
Contact for public enquiries
Takeda Development Centre Europe Limited

United Kingdom
Tel. +44 (0)203 116 8000 
E-mail: paediatrics@tgrd.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating